Synopsis : ION Geophysical Corporation (NYSE: IO) today announced that it received notice on January 31, 2022 from the New York Stock…
Pharmanews
-
-
RegulatorySanofiU.S FDA
FDA approves Enjaymo™ (sutimlimab-jome), First Treatment for use in Patients with Cold Agglutinin Disease
by adminby adminSummary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment…
-
Agrochemicals
Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
by adminby adminSynopsis : Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative…
-
Synopsis : Sanofi has been a global healthcare leader that has brought forth treatments for rare diseases and established standard-of-care therapeutics for…
-
CompaniesPfizer
Valneva and Pfizer report further positive Phase 2 data for Lyme disease vaccine candidate
by adminby adminSynopsis : Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive…
-
AgrochemicalsPharma Science & Research
Three exposures to spike protein allow people to develop broad antibody immunity – also against Omicron
by adminby adminSummary : Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is…
-
AgrochemicalsGlobal Market
OceanFirst Financial Corp. Announces Acquisition of Trident Abstract Title Agency, LLC
by adminby adminSummary : OceanFirst Financial Corp. (NASDAQ:”OCFC”), (the “Company”), the holding company for OceanFirst Bank N.A. (the “Bank”), today, announced the Company has signed…
-
AgrochemicalsGlobal Market
Verizon Business helps secure Australia’s International COVID-19 Vaccination Certificate
by adminby adminSummary : -As Australians gear up for the further reopening of international travel lanes in 2022, proof of COVID-19 vaccination is a…
-
Pharma Science & Research
Mersana, Janssen Come Together in Potential $1B ADC Deal
by adminby adminSummary : On Thursday, Mersana Therapeutics signed a research and licensing deal with Janssen Biotech to access each other’s proprietary technology in…
-
CompaniesPfizer
Pfizer Alleges Stolen Trade Secrets at Heart of Regor Therapeutics Launch
by adminby adminSynopsis : A $1.5 billion diabetes partnership between Eli Lilly and China-based Regor Therapeutics Group is at the center of a lawsuit…